PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
NASDAQ · Healthcare · Medical - Devices · US
$1.37
−0.72%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.13
- Revenue estimate
- $43.6M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.13
- Revenue actual
- $39.0M
- Revenue estimate
- $42.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +20.5%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.13 | -$0.14 | Miss -9.38% | $39.0M |
| May 7, 2026 | -$0.17 | -$0.12 | Beat 29.41% | $37.2M |
| Feb 12, 2026 | -$0.19 | -$0.12 | Beat 36.84% | $44.6M |
| Nov 5, 2025 | -$0.16 | -$0.12 | Beat 25.00% | $38.4M |
| Aug 7, 2025 | -$0.18 | -$0.13 | Beat 27.78% | $39.8M |
| May 8, 2025 | -$0.19 | -$0.15 | Beat 21.05% | $37.2M |
| Feb 13, 2025 | -$0.20 | -$0.20 | In line | $39.2M |
| Nov 7, 2024 | -$0.20 | -$0.17 | Beat 15.00% | $40.0M |
| May 9, 2024 | -$0.26 | -$0.26 | In line | $38.8M |
| Feb 15, 2024 | -$0.31 | -$0.27 | Beat 12.90% | $58.4M |
| Aug 2, 2023 | -$0.34 | -$0.26 | Beat 23.53% | $47.6M |
| May 2, 2023 | -$0.33 | -$0.31 | Beat 6.06% | $38.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 9, 2027